📊 Stryker Corporation (SYK) presents an intriguing proposition for dividend-focused investors. This analysis highlights the corporation's consistent dividend history, marked by a 36-year streak of payouts. With a current dividend yield of 1.11%, Stryker demonstrates a commitment to rewarding its shareholders amidst steady market cap growth. However, to fully understand the potential and risk, one must also consider the company's financial dynamics and market positioning.
| Metric | Value |
|---|---|
| Sector | Health Care Equipment |
| Dividend Yield | 1.11% |
| Current Dividend Per Share | 3.36 USD |
| Dividend History | 36 years |
| Last Cut or Suspension | None |
🗣️ Stryker's dividend history underscores its stability, enhancing investor confidence through reliability and consistent growth over decades.
| Year | Dividend Per Share |
|---|---|
| 2026 | 1.76 USD |
| 2025 | 3.40 USD |
| 2024 | 3.24 USD |
| 2023 | 3.05 USD |
| 2022 | 2.835 USD |
📈 Over the past 5 years, Stryker has shown moderate but consistent dividend growth of 7.62%, reflecting a healthy financial performance trajectory that aligns with shareholder interests.
| Time | Growth |
|---|---|
| 3 years | 6.25% |
| 5 years | 7.62% |
The average dividend growth is 7.62% over 5 years, showcasing a sustainable increase pattern that investors can rely on for future income streams.
📉 The payout ratios offer insight into Stryker's dividend sustainability. An EPS-based payout ratio of 38.55% and FCF-based ratio of 28.18% suggest conservative yet robust dividend policies aligning with profit retention and future growth potential.
| Key Figure Ratio | |
|---|---|
| EPS-based | 38.55% |
| Free Cash Flow-based | 28.18% |
🔎 Stryker's payout ratios indicate prudent financial management, effectively balancing between rewarding shareholders and strategic reinvestment for growth.
✅Cashflow and capital efficiency indicators are key metrics reflecting a company's ability to sustain operations and invest in growth while fulfilling dividend commitments. Stryker's cash flow metrics highlight a positive financial standing, emphasizing its operational adequacy and capital reinvestment capabilities.
| Year | Free Cash Flow Yield | Earnings Yield | CAPEX to Operating Cash Flow | Stock-based Compensation to Revenue | Free Cash Flow / Operating Cash Flow Ratio |
|---|---|---|---|---|---|
| 2025 | 3.19% | 2.42% | 15.08% | 0.97% | 84.91% |
| 2024 | 2.54% | 2.18% | 17.80% | 1.01% | 82.20% |
| 2023 | 2.76% | 2.78% | 15.49% | 1.00% | 84.51% |
⚠️ These figures indicate Stryker's robust cash flow management and capital efficiency, crucial for continuous investment in business innovation and development.
🗣️ Analyzing the balance sheet and leverage offers insights into a company's financial vulnerabilities and stability. Stryker's balance sheet metrics suggest a well-managed leverage position that supports growth initiatives and mitigates financial risks effectively.
| Year | Debt-to-Equity | Debt-to-Assets | Debt-to-Capital | Net Debt to EBITDA | Current Ratio | Quick Ratio | Financial Leverage |
|---|---|---|---|---|---|---|---|
| 2025 | 0.66 | 0.31 | 0.40 | 1.72 | 1.89 | 1.21 | 2.13 |
| 2024 | 0.68 | 0.33 | 0.41 | 2.12 | 1.95 | 1.32 | 2.08 |
| 2023 | 0.73 | 0.34 | 0.42 | 2.08 | 1.58 | 0.97 | 2.15 |
🔍 The leverage metrics demonstrate Stryker's effective debt management strategy, essential to ensure long-term financial security and flexibility.
⚖️ Stryker’s fundamental strength and profitability metrics are crucial in highlighting its operational efficiency and market competitiveness. These indices reflect the company's capacity to sustain profitability while maintaining strategic reinvestments.
| Year | Return on Equity | Return on Assets | Net Margin | EBIT Margin | EBITDA Margin | Gross Margin | R&D to Revenue |
|---|---|---|---|---|---|---|---|
| 2025 | 14.48% | 6.78% | 12.92% | 20.39% | 25.14% | 63.96% | 6.30% |
| 2024 | 14.51% | 6.97% | 13.25% | 17.21% | 21.85% | 61.87% | 6.26% |
| 2023 | 17.02% | 7.93% | 15.44% | 19.66% | 24.67% | 60.95% | 6.31% |
🏆 These figures underscore Stryker's strong market position, driven by high margins and effective research expenditures supporting sustainable growth.
| Category | Description | Score |
|---|---|---|
| Dividend Yield | Represents the ratio of dividends paid to stock price. | |
| Dividend Stability | Indicates the reliability of dividend payments. | |
| Dividend Growth | Measures the historical increase in dividend payments. | |
| Payout Ratio | Shows the portion of earnings paid to shareholders. | |
| Financial Stability | Assesses the company's ability to maintain operations and finance. | |
| Dividend Continuity | Evaluates the track record of uninterrupted dividend payments. | |
| Cashflow Coverage | Examines the coverage of dividends by cash flows. | |
| Balance Sheet Quality | Measures the health of the balance sheet. |
⭐ Based on the comprehensive evaluation, Stryker Corporation deserves a robust investment rating. Its solid growth history, stable financial metrics, and attractive dividend profile make it an excellent candidate for dividend-focused portfolios, with low risk and high potential for sustained income generation.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.